Product dossierBuilt from registrations, label text and platform-curated data

Juvéderm Ultra 2Juvederm ULTRA 2

Juvéderm Ultra 2 is a Hyaluronic acid filler product (Class III device), registered by Allergan. Linked registrations: EU B-03701487900568, UK PARD-3092004, US P050047. First approved in US on 2006-06-02 (P050047). Data as of 2026-11-09.

  • Regulatory classHyaluronic acid filler · Class III device
  • HolderAllergan
  • JurisdictionsUS · EU · UK
  • Updated2026-11-09 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

Juvéderm Ultra 2

Product
Regulatory class
Class III device
Category
Hyaluronic acid filler
EU · EUDAMED device record
B-03701487900568
UK · MHRA device registration (not an approval)
PARD-3092004
US · FDA PMA
P050047 (link pending review)
Registrant
Allergan Industrie SAS
First approval
Not obtained from an official source
Checked against official page
Not yet checked field by field against the live official page

Public: fields from the registration record.Registrant and dates are from B-03701487900568; 3 registrations linked.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. US

    P050047 first approved

  2. UK

    PARD-3092004 registered

  3. US

    P050047 · P050047/S102

    30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|approval for an additional quality control step during the manufact…

  4. US

    P050047 · P050047/S103

    30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|undefined

  5. US

    P050047 · P050047/S104

    30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|a change in location for manufacturing the tip cap component

  6. US

    P050047 · P050047/S105

    30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|to update the varnish used in the manufacture of Juvederm carton bo…

  7. US

    P050047 · P050047/S098

    Normal 180 Day Track|Change Design/Components/Specifications/Material|Approval for using the sodium hyaluronate manufactured from HTL’s addi…

  8. US

    P050047 · P050047/S107

    30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Approval for an automated Manufacturing Execution System used for t…

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record. Dates on non-Chinese registrations keep the source's wording: UK devices show the registration date (MHRA does not approve them), Australia the ARTG start date, FDA devices the decision date.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

5
  • P050047: 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Approva…2026-08-28
  • P050047: Normal 180 Day Track|Change Design/Components/Specifications/Material|Approval f…2026-08-11
  • P050047: 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|to upda…2025-08-14
  • P050047: 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|a chang…2025-07-14
  • P050047: 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|undefin…2025-04-15

Sources

3